BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7074634)

  • 1. Chromosomes in Hodgkin's disease.
    Rowley JD
    Cancer Treat Rep; 1982 Apr; 66(4):639-43. PubMed ID: 7074634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells.
    Jansen MP; Hopman AH; Haesevoets AM; Gennotte IA; Bot FJ; Arends JW; Ramaekers FC; Schouten HC
    J Pathol; 1998 Jun; 185(2):145-52. PubMed ID: 9713340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
    Jansen MP; Hopman AH; Bot FJ; Haesevoets A; Stevens-Kroef MJ; Arends JW; Jox A; Wolf J; Ramaekers FC; Schouten HC
    J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyotype aberrations and surface marker analyses of the tumor cells of Hodgkin's disease: a case report and review of literature.
    Nagai M; Abe T; Seki S; Minato K; Watanabe S; Shimoyama M
    Jpn J Clin Oncol; 1986 Dec; 16(4):397-406. PubMed ID: 2432293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal abnormalities in Hodgkin's disease.
    Thangavelu M; Le Beau MM
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):221-36. PubMed ID: 2663824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomes in Hodgkin's disease--analysis of involved lymph nodes.
    Ankathil R; Vijayakumar T; Pillai GR; Nair MK
    Neoplasma; 1992; 39(4):245-8. PubMed ID: 1436237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome complement of lymph node cells in Hodgkin's disease.
    Whitelaw DM
    Can Med Assoc J; 1969 Jul; 101(2):74-81. PubMed ID: 4893675
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease.
    Falzetti D; Crescenzi B; Matteuci C; Falini B; Martelli MF; Van Den Berghe H; Mecucci C
    Haematologica; 1999 Apr; 84(4):298-305. PubMed ID: 10190942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute non-lymphocytic leukemia in a lymph node concurrent with Hodgkin's lymphoma.
    Silberman S; Messmore HL
    Ann Clin Lab Sci; 1985; 15(1):83-7. PubMed ID: 3970520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell lymphoma developing in Hodgkin's disease: evidence for two clones.
    Wlodarska I; Delabie J; De Wolf-Peeters C; Mecucci C; Stul M; Verhoef G; Cassiman JJ; Van den Berghe H
    J Pathol; 1993 Jul; 170(3):239-48. PubMed ID: 8133397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Karyotype of peripheral blood lymphocytes in patients treated for Hodgkin disease].
    Cappelaere P; Lai JL; Caty A; Deminatti M; Demaille MC
    Bull Cancer; 1983; 70(1):31-9. PubMed ID: 6839032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of cytogenetics and histopathology in the malignant lymphomata.
    Lawler SD; Reeves BR; Hamlin IM
    Br J Cancer Suppl; 1975 Mar; 2():162-7. PubMed ID: 1182067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant and multiaberrant (rogue) cells in peripheral lymphocytes of Hodgkin's lymphoma patients after chemotherapy.
    Ryabchenko NI; Nasonova VA; Fesenko EV; Kondrashova TV; Antoschina MM; Pavlov VV; Ryabikina NV
    Mutat Res; 2006 Oct; 601(1-2):61-70. PubMed ID: 16828123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic studies in Hodgkin's disease and some other reticuloses.
    Demin AA; Radzhabli SI; Loseva MI; Metelkina NV
    Sov Genet; 1972 Jan; 8(1):96-105. PubMed ID: 4670799
    [No Abstract]   [Full Text] [Related]  

  • 16. Some characteristics of a human cell line (AICHI-4) established from tumorous lymphatic tissue of Hodgkin's disease.
    Ito Y; Shiratori O; Kurita S; Takahashi T; Kurita Y; Ota K
    J Natl Cancer Inst; 1968 Dec; 41(6):1367-75. PubMed ID: 5728341
    [No Abstract]   [Full Text] [Related]  

  • 17. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
    Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
    Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited discussion: Chromosome studies of Hodgkin's disease.
    Mitchell AD
    Natl Cancer Inst Monogr; 1973 May; 36():203-4. PubMed ID: 4744579
    [No Abstract]   [Full Text] [Related]  

  • 19. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and immunologic phenotype findings in Hodgkin's disease.
    Slavutsky I; de Vinuesa ML; Estevez ME; Sen L; de Salum SB
    Cancer Genet Cytogenet; 1985 Mar; 16(2):123-30. PubMed ID: 3871658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.